Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

NASDAQ:PLRX

Overview | Financials
Company Name Pliant Therapeutics, Inc.
Symbol PLRX
Currency USD
Price 15.19
Market Cap 923,573,266
Dividend Yield 0%
52-week-range 10.22 - 19.62
Industry Biotechnology
Sector Healthcare
CEO Dr. Bernard Coulie M.B.A., M.D., MBA, Ph.D.
Website https://pliantrx.com

An error occurred while fetching data.

About Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials.

Related Stocks

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

1.18 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.9 USD

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

0.359 USD

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

50.67 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

4.32 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

33.91 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.265 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

15.255 USD

Financials

Numbers are in millions USD

Numbers are in millions USD